Atlas Trials

Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant Virus

Clinical trial NCT03472326 · TERMINATED

Trial details

NCT number
NCT03472326
Sponsor
Gilead Sciences
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV-1-infection
Start date
2018-04-03
Primary completion
2019-12-09
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.